ARCHIVES

Gleevec For KIT-positive Tumors Shows 92 Percent Overall Survival

This article is from The Cancer Letter archive.

Vol. 34 No. 7 | July 29, 2011

Download PDF Visit The Full Archive

Related Articles

Radiosensitizer Screen Concept OK’d, Acoustic Microscopy Delayed

March 2, 1990

Fibrolast Interferon Contract Signed

May 2, 1980

FDA, NCI Remain At Odds Over Drug approval Guidelines Despite Reconciliation Discussion

October 9, 1987

Funding opportunities listed.

May 7, 2004

Senate Committee Approves $27 Billion for NIH, $4.6 Billion for NCI

August 2, 2002

DCT Board Approves Three New BRMP RFAs For Immunologic Research, $1.5 Million A Year

February 27, 1987